OCTOBER 2023LIFE SCIENCES REVIEW5Xavier Salas, Corporate Legal & Compliance Manager, NeuraxpharmNew Product Liability Directive in Europe: Implications for the Pharmaceutical Industry30LAST WORDSilvy Mardiguian, PhD, Head of Health Economics & Outcomes Research (HEOR), Europe & New Markets,BeiGeneHow Can We Tackle the Health Equity Gap to Innovative Medicines?17Stefano Baila, Managing Director Biologics, EurofinsThe Revolutionary Power of Cell and Gene Therapies20Nelly Marmy Conus, Digital Health Technology Clinical Innovation,Health New Product Development,Business Development & Transformation,Syneos HealthSetting Up Organizations for Long-Term Follow-Up Studies22Chièze Claude, DVM, MBA Deputy Head R&D, Pierre Fabre GroupOpen Innovationin Pharma R&D24Peter René Hesse, Vice President Head of Genomics Business, QIAGENUnlocking The Potential of Next-Generation Sequencing26Itedale Namro Redwan, CSO, CELLINK3D bioprinting: Accelerating Drug Discovery28CXO INSIGHTSCXO INSIGHTS
< Page 4 | Page 6 >